164 related articles for article (PubMed ID: 19458913)
1. The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response.
Liu H; Ubukata H; Tabuchi T; Nakachi T; Nagata H; Shimazaki J; Motohashi G; Konishi S; Nishimura M; Satani T; Hong J; Nakada I; Saniabadi AR; Tabuchi T
Mol Cell Biochem; 2009 Nov; 331(1-2):181-6. PubMed ID: 19458913
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
3. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma.
Koyama S; Koike N; Adachi S
J Cancer Res Clin Oncol; 2001 Jan; 127(1):20-6. PubMed ID: 11206267
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues.
Li Q; Peng J; Li XH; Liu T; Liang QC; Zhang GY
World J Gastroenterol; 2010 Mar; 16(10):1274-8. PubMed ID: 20222173
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Fas, FasL and IFN-gamma in gastric cancer].
Li Z; Wang Z; Zhao Z; Zhang Y; Ke Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):386-9. PubMed ID: 12947554
[TBL] [Abstract][Full Text] [Related]
8. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
9. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.
Zheng HC; Sun JM; Wei ZL; Yang XF; Zhang YC; Xin Y
World J Gastroenterol; 2003 Jul; 9(7):1415-20. PubMed ID: 12854132
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer.
Ohno S; Tachibana M; Shibakita M; Dhar DK; Yoshimura H; Kinugasa S; Kubota H; Masunaga R; Nagasue N
Ann Surg Oncol; 2000 Dec; 7(10):750-7. PubMed ID: 11129423
[TBL] [Abstract][Full Text] [Related]
12. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
Das SN; Khare P; Singh MK; Sharma SC
Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
[TBL] [Abstract][Full Text] [Related]
13. Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer.
Gryko M; Guzińska-Ustymowicz K; Pryczynicz A; Cepowicz D; Kukliński A; Czyżewska J; Kemona A; Kędra B
Folia Histochem Cytobiol; 2011; 49(1):142-7. PubMed ID: 21526501
[TBL] [Abstract][Full Text] [Related]
14. Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissues.
Li Y; Xu DF; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(9):11915-20. PubMed ID: 26617948
[TBL] [Abstract][Full Text] [Related]
15. Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients.
Saito H; Takaya S; Osaki T; Ikeguchi M
Gastric Cancer; 2013 Oct; 16(4):473-9. PubMed ID: 23179366
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.
Zhao XH; Gu SZ; Tian HG; Quan P; Pan BR
World J Gastroenterol; 2005 Jul; 11(25):3846-9. PubMed ID: 15991280
[TBL] [Abstract][Full Text] [Related]
18. Frequent expression of soluble Fas and Fas ligand in Chinese stomach cancer and its preneoplastic lesions.
Li H; Liu N; Guo L; Li JW; Liu J
Int J Mol Med; 2000 May; 5(5):473-6. PubMed ID: 10762649
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of mucosal apoptosis in H pylori-associated gastric ulcer are associated with altered FasL and perforin cytotoxic pathways.
Souza HS; Neves MS; Elia CC; Tortori CJ; Dines I; Martinusso CA; Madi K; Andrade L; Castelo-Branco MT
World J Gastroenterol; 2006 Oct; 12(38):6133-41. PubMed ID: 17036384
[TBL] [Abstract][Full Text] [Related]
20. Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis.
Nagashima H; Mori M; Sadanaga N; Mashino K; Yoshikawa Y; Sugimachi K
Int J Oncol; 2001 Jun; 18(6):1157-62. PubMed ID: 11351245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]